Mabion S.A. (MAB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.308x

Based on the latest financial reports, Mabion S.A. (MAB) has a cash flow conversion efficiency ratio of -0.308x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-12.06 Million ≈ $-3.32 Million USD) by net assets (zł39.09 Million ≈ $10.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MAB days of operational coverage to measure how many days the company can operate on defensive assets alone.

Mabion S.A. - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Mabion S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mabion S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mabion S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hanwha Chemical Corp Pref KO:009835	-0.030x
TechPrecision Corporation Common stock NASDAQ:TPCS	0.023x
US Energy Corp NASDAQ:USEG	-0.006x
Seplat Petroleum Development Company PLC LSE:SEPL	0.367x
INmune Bio Inc NASDAQ:INMB	-0.214x
Culp, Inc. Common Stock NYSE:CULP	-0.022x
Dunia Virtual Online Tbk Pt JK:AREA	0.063x
Otto Holding AS IS:OTTO	0.053x

Annual Cash Flow Conversion Efficiency for Mabion S.A. (2009–2025)

The table below shows the annual cash flow conversion efficiency of Mabion S.A. from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Mabion S.A. market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	zł48.83 Million ≈ $13.44 Million	zł-41.59 Million ≈ $-11.45 Million	-0.852x	-338.12%
2024-12-31	zł111.44 Million ≈ $30.67 Million	zł39.86 Million ≈ $10.97 Million	0.358x	+1905.77%
2023-12-31	zł117.78 Million ≈ $32.41 Million	zł-2.33 Million ≈ $-642.08K	-0.020x	-103.90%
2022-12-31	zł76.51 Million ≈ $21.06 Million	zł38.84 Million ≈ $10.69 Million	0.508x	+182.24%
2021-12-31	zł53.31 Million ≈ $14.67 Million	zł-32.91 Million ≈ $-9.06 Million	-0.617x	-235.56%
2020-12-31	zł-77.39 Million ≈ $-21.30 Million	zł-35.24 Million ≈ $-9.70 Million	0.455x	-70.89%
2019-12-31	zł-21.58 Million ≈ $-5.94 Million	zł-33.76 Million ≈ $-9.29 Million	1.564x	+269.28%
2018-12-31	zł42.14 Million ≈ $11.60 Million	zł-38.94 Million ≈ $-10.72 Million	-0.924x	-192.46%
2017-12-31	zł-54.16 Million ≈ $-14.91 Million	zł-54.13 Million ≈ $-14.90 Million	0.999x	+124.49%
2016-12-31	zł3.73 Million ≈ $1.03 Million	zł-15.22 Million ≈ $-4.19 Million	-4.082x	-1433.70%
2015-12-31	zł127.64 Million ≈ $35.13 Million	zł-33.97 Million ≈ $-9.35 Million	-0.266x	-988.98%
2014-12-31	zł997.84 Million ≈ $274.62 Million	zł-24.39 Million ≈ $-6.71 Million	-0.024x	+53.89%
2013-12-31	zł520.55 Million ≈ $143.26 Million	zł-27.59 Million ≈ $-7.59 Million	-0.053x	-615.46%
2012-12-31	zł1.82 Billion ≈ $502.09 Million	zł-13.51 Million ≈ $-3.72 Million	-0.007x	+98.71%
2011-12-31	zł20.37 Million ≈ $5.60 Million	zł-11.74 Million ≈ $-3.23 Million	-0.576x	-794.40%
2010-12-31	zł21.72 Million ≈ $5.98 Million	zł-1.40 Million ≈ $-385.19K	-0.064x	-101.62%
2009-12-31	zł-74.80K ≈ $-20.59K	zł-298.41K ≈ $-82.13K	3.990x	--

About Mabion S.A.

WAR:MAB Poland Biotechnology

Market Cap

$34.83 Million

zł126.55 Million PLN

Market Cap Rank

#23301 Global

#221 in Poland

Share Price

zł7.83

Change (1 day)

+4.96%

52-Week Range

zł6.82 - zł10.10

All Time High

zł134.60